Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Medtronic plc crawled time : 16:20 save search
SMART trial one-year data demonstrates Medtronic Evolut™ TAVR platform as optimal treatment for severe aortic stenosis in patients with small annulus, which is primarily women
Published: 2024-04-07 (Crawled : 16:20) - prnewswire.com
MDT | $80.38 -1.12% -0.03% 5M
|
Health Technology
| Email alert
Add to watchlist
EW | $88.61 0.98% -0.02% 2M
|
Health Technology
| Email alert
Add to watchlist
treatment for women smart trial platform
Medtronic, DaVita launch Mozarc Medical, aimed at introducing new solutions for patients with kidney failure
Published: 2023-04-01 (Crawled : 16:20) - prnewswire.com
DVA | News | $132.74 -0.87% 0.0% 470K
|
Health Services
| Email alert
Add to watchlist
MDT | $80.38 -1.12% -0.03% 5M
|
Health Technology
| Email alert
Add to watchlist
kidney solutions
Addiction Disorders Drugs Market Report 2022: Sector to Reach $32.65 Billion by 2027 at a CAGR of 6.35%
Published: 2023-01-21 (Crawled : 16:20) - prnewswire.com
GLAXF | News | $19.54 -3.77% -14.18% 170
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
| Email alert
Add to watchlist
PMD | $2.645 2.27% 5.54% 1.4K
|
Health Services
| Email alert
Add to watchlist
NVSEF | News | $96.0 0.94% 6.88% 0
|
Health Technology
| Email alert
Add to watchlist
PRGO | $31.23 2.43% 0.0% 960K
|
Health Technology
| Email alert
Add to watchlist
ALKS | $24.65 1.61% 1.62% 1.7M
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $40.86 -0.92% 1.25% 1.6M
|
Health Technology
| Email alert
Add to watchlist
MDT | $80.38 -1.12% -0.03% 5M
|
Health Technology
| Email alert
Add to watchlist
report market
TCT 2022: SYMPLICITY HTN-3 trial data show sustained long-term blood pressure reductions with Medtronic renal denervation procedure
Published: 2022-09-18 (Crawled : 16:20) - prnewswire.com
MDT | $80.38 -1.12% -0.03% 5M
|
Health Technology
| Email alert
Add to watchlist
blood renal trial
Medtronic Extravascular ICD meets global pivotal clinical trial's safety and effectiveness endpoints
Published: 2022-08-28 (Crawled : 16:20) - prnewswire.com
MDT | $80.38 -1.12% -0.03% 5M
|
Health Technology
| Email alert
Add to watchlist
global
(XENT Alert) Johnson Fistel Investigates Proposed Sale of Intersect ENT; Is $28.25 a Fair Price?
Published: 2021-08-07 (Crawled : 16:20) - prnewswire.com
MDT | $80.38 -1.12% -0.03% 5M
|
Health Technology
| Email alert
Add to watchlist
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
WHLM | $6.25 35.87% 28.46% 700K
|
Commercial Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.